Biomarkers predict outcome in Charcot Marie Tooth Disease 1A

BACKGROUND: Charcot Marie Tooth disease type 1A (CMT1A) is the most common inherited neuropathy, a debilitating disease without known cure. Among CMT1A patients, disease manifestation, progression and severity are strikingly variable, which poses major challenges for the development of new therapies...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Neurol Neurosurg Psychiatry
Main Authors: Fledrich, Robert, Mannil, Manoj, Leha, Andreas, Ehbrecht, Caroline, Solari, Alessandra, Pelayo-Negro, Ana L., Berciano, José, Schlotter-Weigel, Beate, Schnizer, Tuuli J., Prukop, Thomas, Garcia-Angarita, Natalia, Czesnik, Dirk, Haberlová, Jana, Mazanec, Radim, Paulus, Walter, Beissbarth, Tim, Walter, Maggie C., CMT-TRIAAL, Hogrel, Jean-Yves, Dubourg, Odile, Schenone, Angelo, Baets, Jonathan, De Jonghe, Peter, Shy, Michael E., Horvath, Rita, Pareyson, Davide, Seeman, Pavel, Young, Peter, Sereda, Michael W.
Formato: Artigo
Idioma:Inglês
Publicado: 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8265963/
https://ncbi.nlm.nih.gov/pubmed/28860329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2017-315721
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares